Skip to main content

Everads Therapy Ltd

The startup develops a retinal treatment technology that utilizes suprachoroidal injection for targeted drug delivery, addressing the challenges of effective distribution within the eye. This method aims to enhance patient compliance and improve therapeutic outcomes through sustained drug release.

Traction 3/10
Tel Aviv, Israel · HQ
Founded 201711300+ followers
  • Biotechnology
Updated 6 months ago

Funding

Raised to date

$950KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Moshe Weinstein

CEO

Lior Raday

Drug delivery design expert

Product

Features

  • The startup develops a retinal treatment technology that utilizes suprachoroidal injection for targeted drug delivery, addressing the challenges of effective distribution within the eye. This method aims to enhance patient compliance and improve therapeutic outcomes through sustained drug release.
This profile is AI-generated and may contain inaccuracies.